| 영문 | blood volume | 한글 | 혈액량 |
|---|---|---|---|
| 설명 | 체내에 존재하는 혈액의 총량으로서, 보통 리터 또는 체중 1kg에 대하여 리터수로 표시한다. |
||
| 영문 | interstitial therapy | 한글 | 근접치료 |
|---|---|---|---|
| 설명 | 주로 종양의 치료를 목적으로 하여 인체 조직내에 방사선 물질을 삽입하여 방사선을 조사하는 치료법이다. Brachytherapy라고도 한다. |
||
| 영문 | nephritis(interstitial) | 한글 | 콩팥염, 신장염(간질성) |
|---|---|---|---|
| 설명 | 콩팥사이질(renal interstitium: 콩팥의 세뇨관 사이의 결합조직)의 염증. 급성으로 일어나는 간질콩팥염은 대개 많은 약을 복용한 후에 발생하는 데, 열, 피부의 변색, 혈액내의 호산구증 그리고 소변의 감소와 콩팥기능의 감소를 특징으로 한다. 치료는 복용중인 약을 끊고, 부신겉질호르몬제를 투여한다. 콩팥은 각종 노폐물, 전해질, 수분 등을 포함한 요를 생산하여 배출하는 동시에 수소이온, 나트륨, 칼륨, 인산 이온 농도 등을 조절하며 내분비와 외분비 기능에 관여하기도 한다. |
||
| 영문 | heart-lung machine | 한글 | 심장-허파 기계 |
|---|---|---|---|
| 설명 | 심장의 수술에 사용되는 기계로서 심장이 수술을 받고 있는 동안 기능을 하지 못하므로 이 기능을 대신 해주는 기계이다. 이것은 대정맥과 대동맥사이에 연결이 되어서 혈액을 강제로 순환시키면서 대정맥에서 온 피에 산소를 공급하여 대동맥으로 돌려 보내는 역할을 한다. 즉 심장과 폐의 역할을 동시에 하는 기계이다. |
||
| 영문 | total lung capacity | 한글 | 전폐용량, 온허파용량 |
|---|---|---|---|
| 설명 | 폐활량(가능한 한 깊게 들여 마신 시점부터 천천히 한껏 내쉰 용량)에 잔기량(최대 날숨위치에서 폐내에 남은 용량. 약 1,200mL)을 합한 것이다. 건강한 성인은 6,000~7,000mL. 폐기종, 만성 기관지염 등의 폐색성 장애로 증가하게 되는 한편 허파섬유증, 무기폐, 흉수, 흉곽변형 등의 구속성 장애로 감소한다. |
||
| DILD | diffuse infiltrative lung disease; diffuse interstitial lung disease |
|---|---|
| JVP | [POMD P 49 - 52] 1) Jugular Vein Pressure 2) Jugular Venous Pulse ... |
| ILD | interstitial lung disease; intraoperative localization device; ischemic leg disease; ischemic limb d... |
| CD | cadaver donor; canine distemper; canine dose; carbohydrate dehydratase; carbon dioxide; cardiac dise... |
| HD | Haab-Dimmer [syndrome]; Hajna-Damon [broth]; Hansen disease; hearing distance; heart disease; helix ... |
| ILD | Interstitial Lung Disease |
|---|---|
| DILD | diffuse interstitial lung disease |
| Ca2+ | C and increased |
| 125I | Increased |
| Na | increased as |
| interstitial lung disease with increased volume | <radiology> Cystic fibrosis (CF), eosinophilic granuloma (EG), lymphangioleiomyomatosis (LAM) (12 Dec 1998) |
|---|
| apical interstitial lung disease | <radiology> A radiological diagnosis where fibrosis is seen in the apices (upper sections) of the lungs. Likely causes include: cystic fibrosis, ankylosing spondylitis, sarcoidosis, silicosis, eosinophlic granuloma, TB and fungus, particularly aspergillus infection. (25 Jun 1999) |
|---|---|
| basilar interstitial lung disease | <radiology> B bronchiectasis, A asbestosis, D drugs / DIP, L lymphangitic metastasis / LAM, A aspiration, S sarcoidosis, S scleroderma (12 Dec 1998) |
| interstitial lung disease | <chest medicine> A group of lung disorders which result in scarring and dysfunction of the alveolus (air sac) in the lung. This results in poor oxygen diffusion from the air into the bloodstream. Widespread inflammation in the lung leads to fibrosis (scarring). Causes include chronic exposure to organic and inorganic dusts, fumes, vapors, radiation, medications and certain lung infections. Examples include asbestosis, silicosis, coal worker's pneumoconiosis and diffuse interstitial fibrosis. Smoking increases the risk in all cases. (27 Sep 1997) |
| increased markings emphysema | A term applied to mixed obstructive lung disease in which radiographic findings of emphysema coexist with nonvascular shadows, probably related to bronchial inflammation. (05 Mar 2000) |
| increased skull thickness | <radiology> Generalised, chronic severe anaemia (e.g. Thalassaemia, SSD), cerebral atrophy following shunting of hydrocephalus, Engelmann disease: mainly skull base, hyperparathyroidism, acromegaly, osteopetrosis, chronic dilantin ingestion focal, meningioma, fibrous dysplasia, Dyke-Davidoff syndrome, hyperostosis frontalis interna, metastases (12 Dec 1998) |
| lung volume measurements | Measurement of the amount of air that the lungs may contain at various points in the respiratory cycle. (12 Dec 1998) |
| lung diseases, interstitial | A heterogeneous group of noninfectious, nonmalignant disorders of the lower respiratory tract, affecting primarily the alveolar wall structures but also often involving the small airways and blood vessels of the lung parenchyma. "interstitial" refers to the fact that the interstitium of the alveolar walls is thickened, usually by fibrosis. This group of diseases is usually inflammatory. (12 Dec 1998) |
| interstitial disease | A disease occurring chiefly in the connective-tissue framework of an organ, the parenchyma suffering secondarily. (05 Mar 2000) |
| asbestos lung disease | <radiology> Pleural plaques, earliest finding, may be only evidence, parietal pleura, 15-20 yrs after exposure, calcified after ca. 30 yrs, asbestosis, interstitial lung disease, perihilar regions to lung bases, shaggy heart, no cavitation or progressive massive fibrosis as in silicosis, crocidolite (blue) form most carcinogenic, associated with: malignant pleural mesothelioma, peritoneal mesothelioma, GI-tract malignancy (12 Dec 1998) |
| parasitic eosinophilic lung disease | <radiology> All are metazoans (mostly nematodes), Ascaris, Strongyloides, Ancyclostoma, Schistosoma, tropical pulmonary eosinophilia, pulmonary larva migrans (12 Dec 1998) |
| rheumatoid lung disease | <radiology> Pleural effusion, most common finding, seen mostly in males (although RA more common in females), diffuse interstitial fibrosis, necrobiotic nodules, Caplan syndrome, nodules and pneumoeritis and hypertension (12 Dec 1998) |
| drug-induced eosinophilic lung disease | <radiology> Diffuse reticular pattern: nitrofurantoin, Loeffler-like pattern: penicillin, sulfonamides, ASA, para-ASA, imipramine, HCTZ, cromolyn sodium see: eosinophilic lung disease (12 Dec 1998) |
| obstructive lung disease | <chest medicine> A form of lung disease that manifests as acute or chronic, narrowing or blockage of the smaller airways in the lungs, causing increased resistance to airflow in the bronchial tubes (for example asthma, silicosis, chronic obstructive pulmonary disease from smoking). (27 Sep 1997) |
| occupational lung disease | Fibrosis and scarring of the lungs secondary to the repeated inhalation of dust associated with some occupation. Examples include silica, asbestos and coal dust exposure. (27 Sep 1997) |
| eosinophilic lung disease | <radiology> Idiopathic: Loeffler pneumonia, chronic eosinophilic pneumonia, hypereosinophilic syndrome, specific: drugs (e.g., nitrofurantoin), parasites, fungi (ABPA, bronchocentric granulomatosis), vasculitis / granulomatosis: Wegener's granulomatosis, polyarteritis nodosa, sarcoidal angiitis (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|